Related references
Note: Only part of the references are listed.Genetic Biomarkers in Melanoma of the Ocular Region: What the Medical Oncologist Should Know
Kalijn Fredrike Bol et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Conjunctival melanoma copy number alterations and correlation with mutation status, tumor features, and clinical outcome
Nihal Kenawy et al.
PIGMENT CELL & MELANOMA RESEARCH (2019)
Interferon Alpha 2a and 2b in Ophthalmology: A Review
Natalia Lewczuk et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2019)
Multicenter, International Assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma
Puneet Jain et al.
JAMA OPHTHALMOLOGY (2019)
Greater Tumor Thickness, Ulceration, and Positive Sentinel Lymph Node Are Associated With Worse Prognosis in Patients With Conjunctival Melanoma Implications for Future AJCC Classifications
Bita Esmaeli et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)
Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine
Liang Cheng et al.
MODERN PATHOLOGY (2018)
NF1 mutations in conjunctival melanoma
S. L. Scholz et al.
BRITISH JOURNAL OF CANCER (2018)
Combined mutation and copy-number variation detection by targeted next-generation sequencing in uveal melanoma
Kyra N. Smit et al.
MODERN PATHOLOGY (2018)
Conjunctival Melanoma - Epidemiological Trends and Features
Snjezana Kastelan et al.
PATHOLOGY & ONCOLOGY RESEARCH (2018)
Treatment of conjunctival melanoma in a Dutch referral centre
Niels J. Brouwer et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2018)
Sun Exposure and Melanoma, Certainties and Weaknesses of the Present Knowledge
Mariachiara Arisi et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Prognostic impact and concordance of TERT promoter mutation and protein expression in matched primary and metastatic cutaneous melanoma
Emilia Hugdahl et al.
BRITISH JOURNAL OF CANCER (2018)
Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy
Jinfeng Cao et al.
ONCOTARGET (2017)
Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble
Vasilis Kontis et al.
LANCET (2017)
PD-L1/PD-1 expression and tumor-infiltrating lymphocytes in conjunctival melanoma
Jinfeng Cao et al.
ONCOTARGET (2017)
Systemic BRAF/MEK Inhibitors as a Potential Treatment Option in Metastatic Conjunctival Melanoma
Joel M. Mor et al.
OCULAR ONCOLOGY AND PATHOLOGY (2017)
BRAF inhibitors: efficacious and tolerable in BRAF-mutant acral and mucosal melanoma
X. Bai et al.
NEOPLASMA (2017)
UV light signature in conjunctival melanoma; not only skin should be protected from solar radiation
Carlo Rivolta et al.
JOURNAL OF HUMAN GENETICS (2016)
BRAF mutations in conjunctival melanoma: investigation of incidence, clinicopathological features, prognosis and paired premalignant lesions
Ann-Cathrine Larsen et al.
ACTA OPHTHALMOLOGICA (2016)
TERT Promoter Mutations in Skin Cancer: The Effects of Sun Exposure and X-Irradiation
Helena Populo et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Prevalence and Implications of TERT Promoter Mutation in Uveal and Conjunctival Melanoma and in Benign and Premalignant Conjunctival Melanocytic Lesions
Anna E. Koopmans et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)
Management of conjunctival malignant melanoma: a review and update
James R. Wong et al.
EXPERT REVIEW OF OPHTHALMOLOGY (2014)
TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours
K. G. Griewank et al.
BRITISH JOURNAL OF CANCER (2013)
Conjunctival Melanomas Harbor BRAF and NRAS Mutations and Copy Number Changes Similar to Cutaneous and Mucosal Melanomas
Klaus G. Griewank et al.
CLINICAL CANCER RESEARCH (2013)
Multiplex Ligation-Dependent Probe Amplification of Conjunctival Melanoma Reveals Common BRAF V600E Gene Mutation and Gene Copy Number Changes
Sarah L. Lake et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: Outcome analysis from a single-institution prospectively collected database
M. Mandala et al.
EUROPEAN JOURNAL OF CANCER (2009)
An audit of conjunctival melanoma treatment in Liverpool
B. Damato et al.
EYE (2009)
Conjunctival melanoma in the Netherlands: A nationwide study
GS Missotten et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma - An analysis of 3661 patients from a single center
MF Azzola et al.
CANCER (2003)
Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study
G Anastassiou et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2002)
Share Paper
